Myriad Genetics, Inc. (MYGN)

Myriad Genetics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020
Period Ending	Nov 4, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Jun 30, 2020
Market Capitalization	1,568	1,697	1,176	2,204	1,487	845
Market Cap Growth	17.11%	44.34%	-46.65%	48.19%	75.92%	-58.52%
Enterprise Value	1,680	1,812	1,054	1,884	1,588	915
Last Close Price	17.99	19.14	14.51	27.60	19.77	11.34
PE Ratio	-	-6.02	-10.44	-78.86	-6.60	-4.22
PS Ratio	1.96	2.25	1.73	3.19	2.67	1.32
PB Ratio	2.21	2.17	1.33	2.28	1.69	0.92
P/FCF Ratio	-17.63	-9.75	-7.76	3673.31	-37.09	16.74
P/OCF Ratio	-23.86	-15.30	-11.06	118.49	-55.29	13.93
EV/Sales Ratio	2.09	2.41	1.55	2.73	2.85	1.43
EV/EBITDA Ratio	-46.05	-21.91	-12.70	-29.48	-12.87	-15.25
EV/EBIT Ratio	-21.84	-13.05	-7.77	-14.87	-8.15	-6.93
EV/FCF Ratio	-17.96	-10.41	-6.95	3139.65	-39.61	18.12
Debt / Equity Ratio	0.19	0.19	0.16	0.10	0.33	0.32
Debt / FCF Ratio	-1.14	-0.87	-0.96	153.83	-7.21	5.84
Asset Turnover	0.71	0.64	0.54	0.50	-	0.43
Inventory Turnover	10.21	11.22	11.41	9.32	-	6.15
Quick Ratio	1.44	1.64	1.58	2.11	1.65	1.96
Current Ratio	1.96	2.01	2.00	2.37	2.67	2.26
Return on Equity (ROE)	-21.03%	-31.55%	-12.08%	-2.94%	-	-19.89%
Return on Assets (ROA)	-5.68%	-7.40%	-6.73%	-5.78%	-	-5.56%
Return on Capital (ROIC)	-7.08%	-8.83%	-8.11%	-7.10%	-	-6.51%
Earnings Yield	-9.50%	-15.51%	-9.53%	-1.23%	-15.04%	-23.60%
FCF Yield	-7.69%	-10.26%	-12.89%	0.03%	-2.70%	5.97%
Buyback Yield / Dilution	-7.39%	-2.73%	-3.33%	-4.31%	-0.64%	2.24%
Total Shareholder Return	-7.39%	-2.73%	-3.33%	-4.31%	-0.64%	2.24%

Source: S&P Capital IQ. Standard template. Financial Sources.